Mengubas K - Search Results

1

Ceramide-induced killing of normal and malignant human lymphocytes is by a non-apoptotic mechanism.

Mengubas K, Riordan FA, Bravery CA, Lewin J, Owens DL, Mehta AB, Hoffbrand AV, Wickremasinghe RG. Mengubas K, et al. Oncogene. 1999 Apr 15;18(15):2499-506. doi: 10.1038/sj.onc.1202622. Oncogene. 1999. PMID: 10229201

2

Co-ordinated downregulation of bcl-2 and bax expression during granulocytic and macrophage-like differentiation of the HL60 promyelocytic leukaemia cell line.

Mengubas K, Riordan FA, Hoffbrand AV, Wickremasinghe RG. Mengubas K, et al. FEBS Lett. 1996 Oct 7;394(3):356-60. doi: 10.1016/0014-5793(96)00983-0. FEBS Lett. 1996. PMID: 8830674 Free article.

3

Herbimycin A accelerates the induction of apoptosis following etoposide treatment or gamma-irradiation of bcr/abl-positive leukaemia cells.

Riordan FA, Bravery CA, Mengubas K, Ray N, Borthwick NJ, Akbar AN, Hart SM, Hoffbrand AV, Mehta AB, Wickremasinghe RG. Riordan FA, et al. Among authors: mengubas k. Oncogene. 1998 Mar 26;16(12):1533-42. doi: 10.1038/sj.onc.1201680. Oncogene. 1998. PMID: 9569020

4

Killing of T lymphocytes by synthetic ceramide is by a nonapoptotic mechanism and is abrogated following mitogenic activation.

Mengubas K, Fahey AA, Lewin J, Mehta AB, Hoffbrand AV, Wickremasinghe RG. Mengubas K, et al. Exp Cell Res. 1999 May 25;249(1):116-22. doi: 10.1006/excr.1999.4474. Exp Cell Res. 1999. PMID: 10328959

5

Inactivation of calcium ion-regulating inositol polyphosphate second messengers is impaired in subpopulations of human leukemia cells.

Mengubas K, Jabbar SA, Nye KE, Wilkes S, Hoffbrand AV, Wickremasinghe RG. Mengubas K, et al. Leukemia. 1994 Oct;8(10):1718-25. Leukemia. 1994. PMID: 7934169

6

Zinc and selenium status in pediatric malignant lymphomas.

Cavdar AO, Gözdaşoğlu S, Babacan E, Mengübaş K, Unal E, Yavuz G, Taçyildiz N. Cavdar AO, et al. Among authors: mengubas k. Nutr Cancer. 2009;61(6):888-90. doi: 10.1080/01635580903285189. Nutr Cancer. 2009. PMID: 20155631

7

Trace Element Analyses (Zinc and Selenium) in Pediatric Malignant Lymphomas.

Çavdar AO, Ünal E, Babacan E, Gözdaşoğlu S, Yavuz G, Mengübaş K, Pamir A, Taçyıldız N. Çavdar AO, et al. Among authors: mengubas k. Turk J Haematol. 2002 Jun 5;19(2):239-44. Turk J Haematol. 2002. PMID: 27264765

8

Selenium status of healthy Turkish children.

Mengübaş K, Diab NA, Gökmen G, Ataman OY, Cavdar A, Cin S. Mengübaş K, et al. Biol Trace Elem Res. 1996 Aug;54(2):163-72. doi: 10.1007/BF02786263. Biol Trace Elem Res. 1996. PMID: 8886316

9

Late effects of chemoradiotherapy in pediatric Hodgkin's disease.

Gözdasoglu S, Cavdar AO, Babacan E, Mengübas K, Yavuz G, Unal E, Pamir A, Ocal G, Haluk Gökçora I. Gözdasoglu S, et al. Among authors: mengubas k. J Chemother. 1995 Oct;7(5):463-6. doi: 10.1179/joc.1995.7.5.463. J Chemother. 1995. PMID: 8596134

10

Hepatoma with right atrial extension.

Imamoğlu A, Akalin H, Corapçioğlu T, Girgin N, Mengübaş K, Erol C. Imamoğlu A, et al. Among authors: mengubas k. Pediatr Cardiol. 1989 Fall;10(4):236-7. doi: 10.1007/BF02083301. Pediatr Cardiol. 1989. PMID: 2556690

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

10 results

Search Page

Filters